Source-grounded facts extracted from Lifeloc Technologies, Inc's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Lifeloc Technologies, Inc incurred loan of $500,000 with Vern Kornelsen at 10.5% per annum (subject to upward adjustment based on changes in the prime rate maturing December 31, 2031.
“On May 4, 2026, Lifeloc Technologies, Inc. (the “Company”) entered into a loan transaction with Vern Kornelsen, the Company’s Chief Financial Officer and Chairman of the Board. The transaction consists of a Promissory Note dated May 1, 2026 (the “Note”) in the principal amount of $500,000.”
Lifeloc Technologies, Inc reported year ended December 31, 2025 results: revenue $9.027 million, net income ($2.470) million, EPS ($0.90) per diluted share.
“devices, has announced financial results for the 2025 fiscal year ended December 31, 2025. 2025 Financial Highlights Lifeloc Technologies reported revenue growth of 6% to $9.027 million for 2025, compared to net revenue of $8.538 million for 2024. We realized a net loss of ($2.470) million , or ($0.90) per diluted share for the year ending December 31, 2025”
Adam Kashenberg was appointed as Director at Lifeloc Technologies, Inc.
“On July 23, 2024, in accordance with the Company’s Amended and Restated Bylaws (the “Bylaws”), the Board appointed Adam Kashenberg to fill the vacancy on the Board and on the Company’s audit committee created by Mr. Greenlee’s resignation.”
Robert Greenlee resigned as Director at Lifeloc Technologies, Inc.
“On July 22, 2024, Robert Greenlee notified the Company by letter of his resignation from the board of directors (the “Board”) of the Company.”
Lifeloc Technologies, Inc reported first quarter ended March 31, 2024 results: revenue $2.153 million, net income $(284) thousand, EPS $(0.12) per diluted share.
“Lifeloc posted quarterly net revenue of $2.153 million resulting in a quarterly net loss of $(284) thousand, or $(0.12) per diluted share.”
Lifeloc Technologies, Inc reported fiscal year ended December 31, 2023 results: revenue $9.330 million, net income $206 thousand, EPS $0.08 per diluted share.
“Lifeloc Technologies posted annual net revenue of $9.330 million resulting in a net profit of $206 thousand in 2023, or $0.08 per diluted share.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.